Therapeutic Drug Monitoring (TDM) Of Rituximab To Predict Early B-Cell Repopulation In Children
Sunday, May 5, 2024
2:30 PM – 2:45 PM ET
Location: Metro Toronto Convention Centre: 501
CE Enduring CME: 0.25
Publication Number: 2455.3
Bindiya Chugani, The Hospital for Sick Children, Toronto, ON, Canada; Joley Johnstone, Sick Kids Hosptial, Toronto, ON, Canada; Eluen A. Yeh, University of Toronto, Grimsby, ON, ON, Canada; Rae S. M.. Yeung, The Hospital for Sick Children, Toronto, ON, Canada; Floris Loeff, Sanquin Diagnostic Services, Amsterdam, Noord-Holland, Netherlands; Linda T. Hiraki, The Hospital for Sick Children, Toronto, ON, Canada; Andrea Knight, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada; Deborah Levy, The Hospital for Sick Children, Toronto, ON, Canada; Ruud H.J.. Verstegen, The Hospital for Sick Children, Toronto, ON, Canada
Presenting Author(s)
Ruud H.J. Verstegen, MD PhD (he/him/his)
Paediatric Rheumatologist & Clinical Pharmacologist The Hospital for Sick Children Toronto, Ontario, Canada